Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novartis India Limited (NSE: NOVARTIND)

 
NOVARTIND Technical Analysis
1
As on N/A NOVARTIND SHARE Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVARTINDSHARE Price

Open N/A Change Price %
High N/A 1 Day N/A N/A
Low N/A 1 Week N/A N/A
Close N/A 1 Month N/A N/A
Volume N/A 1 Year N/A N/A
52 Week High N/A | 52 Week Low N/A
 
NSE INDIA Most Active Stocks
IDEA 13.90 6.11%
YESBANK 25.95 1.96%
KOTAKBANK 1642.45 -10.87%
SOUTHBANK 30.40 4.47%
SAIL 164.95 0.18%
PNB 135.90 2.18%
TATASTEEL 167.70 1.30%
AXISBANK 1127.00 6.00%
IRFC 150.25 0.84%
IOB 66.90 5.77%
 
NSE INDIA Top Gainers Stocks
ROML 75.65 19.98%
POWERINDIA 9329.50 13.60%
GPTINFRA 211.80 12.51%
NEOGEN 1557.75 12.25%
PNC 65.00 11.02%
PNC 65.00 11.02%
PNC 65.00 11.02%
PNC 65.00 11.02%
MOIL 430.70 10.88%
GODFRYPHLP 3449.70 10.17%
 
NSE INDIA Top Losers Stocks
KOTAKBANK 1642.45 -10.87%
GLS 750.50 -9.20%
EXCEL 0.50 -9.09%
DALBHARAT 1806.45 -7.97%
WEIZMANIND 132.50 -6.85%
5PAISA 536.35 -6.77%
CELEBRITY 19.85 -6.59%
BBL 3135.00 -5.60%
BBL 3135.00 -5.60%
BBL 3135.00 -5.60%
 
 
NOVARTIND
Daily Charts		 NOVARTIND
Intraday Charts		 Whats New @
Bazaartrend		 NOVARTIND
Free Analysis
 
NOVARTIND Important Levels Intraday
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
 
NOVARTIND Target April 2024
Share
4th UP Target
3rd UP Target
2nd UP Target
1st UP Target
1st DOWN Target
2nd DOWN Target
3rd DOWN Target
4th DOWN Target
 
NOVARTIND Weekly Target
4th UP Target
3rd UP Target
2nd UP Target
1st UP Target
1st DOWN Target
2nd DOWN Target
3rd DOWN Target
4th DOWN Target
 
NOVARTIND Target2024
4th UP Target
3rd UP Target
2nd UP Target
1st UP Target
1st DOWN Target
2nd DOWN Target
3rd DOWN Target
4th DOWN Target
 
 
NOVARTIND Synopsis Technicals View
50 Day EMA N/A (Short Term)
 N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
 
NOVARTIND Other Details
Segment EQ
Market Capital 18732115968.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
NOVARTIND Address
NOVARTIND
 
NOVARTIND Latest News
 
Your Comments and Response on Novartis India Limited
 
NOVARTIND Business Profile
Novartis India Limited operates as a healthcare company in India. It offers pharmaceutical products in the areas of bone and pain, calcium portfolio, gynecology, and neurosciences, as well as generics products in the areas of gynecology, anti-TB, and anti-infectives. The company provides central nervous system products under the Tegrital and Exelon brands; pain and inflammation products under the Voveran brand; and transplantation/immunology products under the Simulect, Certican, Myfortic, and Sandimmun Neoral brands. The company was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG. Address: Inspire BKC, G Block, Mumbai, India, 400051
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service